Snowden Capital Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.19M Sell
20,393
-2,864
-12% -$308K 0.06% 286
2025
Q1
$2.35M Buy
23,257
+1,860
+9% +$188K 0.08% 266
2024
Q4
$1.91M Sell
21,397
-2,314
-10% -$207K 0.06% 313
2024
Q3
$1.99M Sell
23,711
-486
-2% -$40.7K 0.06% 323
2024
Q2
$1.86M Sell
24,197
-471
-2% -$36.3K 0.06% 331
2024
Q1
$1.69M Buy
24,668
+3,247
+15% +$222K 0.05% 360
2023
Q4
$1.24M Sell
21,421
-1,949
-8% -$113K 0.05% 388
2023
Q3
$1.23M Sell
23,370
-578
-2% -$30.5K 0.05% 361
2023
Q2
$1.3M Sell
23,948
-4,485
-16% -$243K 0.05% 391
2023
Q1
$1.42M Buy
28,433
+3,392
+14% +$170K 0.06% 368
2022
Q4
$1.16M Sell
25,041
-247
-1% -$11.4K 0.05% 418
2022
Q3
$979K Buy
25,288
+207
+0.8% +$8.01K 0.04% 429
2022
Q2
$934K Buy
25,081
+878
+4% +$32.7K 0.04% 436
2022
Q1
$1.07M Buy
24,203
+12,096
+100% +$535K 0.04% 411
2021
Q4
$514K Sell
12,107
-11,631
-49% -$494K 0.03% 445
2021
Q3
$1.03M Buy
23,738
+1,104
+5% +$47.9K 0.05% 363
2021
Q2
$968K Sell
22,634
-1,160
-5% -$49.6K 0.05% 383
2021
Q1
$920K Buy
23,794
+7,538
+46% +$291K 0.05% 365
2020
Q4
$584K Buy
16,256
+426
+3% +$15.3K 0.04% 405
2020
Q3
$605K Buy
15,830
+427
+3% +$16.3K 0.05% 350
2020
Q2
$541K Buy
15,403
+1,471
+11% +$51.6K 0.05% 356
2020
Q1
$455K Buy
13,932
+1,720
+14% +$56.1K 0.05% 354
2019
Q4
$552K Buy
12,212
+776
+7% +$35.1K 0.05% 371
2019
Q3
$465K Buy
11,436
+526
+5% +$21.4K 0.05% 355
2019
Q2
$469K Sell
10,910
-3
-0% -$129 0.05% 335
2019
Q1
$419K Buy
+10,913
New +$419K 0.05% 343